EMPLOYMENT AGREEMENTEmployment Agreement • May 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of February 26, 2024, between SIGA Technologies, Inc., a Delaware corporation (the “Company”), and Larry Miller (“Executive”).
Re: Letter Amendment to Promotion AgreementPromotion Agreement • May 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
Reference is hereby made to that certain Promotion Agreement, dated as of May 31, 2019 (as amended by Amendment No. 1, dated as of September 10, 2020, and the Letter Amendment, dated as of February 29, 2024, and as otherwise amended, supplemented or modified prior to the date hereof, the “Agreement”), by and between SIGA Technologies, Inc. (“SIGA”) and Meridian Medical Technologies, LLC (formerly known as Meridian Medical Technologies, Inc.) (“MMT”) (each, a “Party” and, collectively, the “Parties”). Capitalized terms used but not otherwise defined in this letter (this “Letter Amendment”) have their meanings set forth in the Agreement.
CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY “[***],” HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRATANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDMENT #2 TO THE PROMOTION AGREEMENTPromotion Agreement • May 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
This AMENDMENT #2 TO THE PROMOTION AGREEMENT (this “Amendment No. 2”) is entered into as of March 27, 2024, between SIGA TECHNOLOGIES, INC., a Delaware corporation (“SIGA”), and MERIDIAN MEDICAL TECHNOLOGIES, LLC (f/k/a Meridian Medical Technologies, Inc.), a Delaware limited liability company (“MMT”). SIGA and MMT are each referred to herein as a “Party” or collectively as the “Parties”.
Re: Letter Amendment to Promotion AgreementPromotion Agreement • May 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
Reference is hereby made to that certain Promotion Agreement, dated as of May 31, 2019 (as amended prior to the date hereof, the “Agreement”), by and between SIGA Technologies, Inc. (“SIGA”) and Meridian Medical Technologies, LLC (formerly known as Meridian Medical Technologies, Inc.) (“MMT”) (each, a “Party” and, collectively, the “Parties”). Capitalized terms used but not otherwise defined in this letter (this “Letter Amendment”) have their meanings set forth in the Agreement.
AMENDMENT #1 TO THE PROMOTION AGREEMENTPromotion Agreement • May 7th, 2024 • Siga Technologies Inc • Pharmaceutical preparations
This AMENDMENT #1 TO THE PROMOTION AGREEMENT (“Amendment No. 1”) is entered into and made effective as of September 10, 2020 (the “Amendment No. 1 Effective Date”) between SIGA Technologies, Inc., a Delaware corporation, having an address at 31 East 62nd Street, New York, NY 10065 (“SIGA”), and Meridian Medical Technologies, Inc., a Pfizer company, and Delaware corporation, having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046 (“MMT”). SIGA and MMT are each referred to herein as a “Party” or collectively as the “Parties.”
